Alexion Pharma (ALXN) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Operating income: 194.71M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Operating income: 194.71M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Alexion Pharma (NASDAQ: ALXN) reported Q4 EPS of $1.30, $0.02 better than the analyst estimate of $1.28. Revenue for the quarter came in at $599 million versus the consensus estimate of $590.5 million.
For earnings history and earnings-related data on Alexion Pharma (ALXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Optimum Communications gets NYSE non-compliance notice over stock price
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
